Analyst Price Targets — GLPG
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 24, 2026 7:21 pm | Brian Abrahams | RBC Capital | $33.00 | $34.36 | StreetInsider | Galapagos NV (GLPG) PT Raised to $33 at RBC Capital |
| October 22, 2025 12:22 pm | Brian Abrahams | RBC Capital | $28.00 | $31.43 | TheFly | Galapagos price target raised to $28 from $27 at RBC Capital |
| October 21, 2025 8:08 pm | — | Leerink Partners | $40.00 | $31.43 | TheFly | Galapagos upgraded to Outperform from Market Perform at Leerink |
| July 7, 2021 12:00 am | David Evans | Kepler Capital | $85.92 | $66.78 | Investing | Kepler Capital Stick to Their Hold Rating for Galapagos |
| May 9, 2021 12:00 am | Derek Archila | Wells Fargo | $97.00 | $73.54 | StreetInsider | Galapagos NV (GLPG) PT Raised to $97 at Stifel |
| April 12, 2021 12:00 am | Laura Sutcliffe | UBS | $83.74 | $77.39 | TheFly | Galapagos price target raised to EUR 77 from EUR 75 at UBS |
Latest News for GLPG
Galapagos NV (NASDAQ: GLPG - Get Free Report)'s share price crossed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $32.63 and traded as low as $28.27. Galapagos shares last traded at $28.93, with a volume of 249,516 shares changing hands. Analysts Set New Price Targets Several
De nieuwe samenwerkingsstructuur levert aanzienlijk verbeterde financiële voorwaarden en flexibiliteit voor Galapagos op Na deze transactie blijft de Vennootschap over het grootste deel van haar liquide middelen beschikken voor bijkomende strategische transacties en andere prioriteiten van kapitaalallocatie Kans om met gamgertamig een potentieel first-in-class and best-in-class T-cell-engager in auto-immuunziekten…
New collaboration structure achieves meaningfully improved financial terms and flexibility for Galapagos Following this transaction, the Company will continue to have a majority of its cash remaining for additional strategic transactions and other capital allocation priorities Opportunity to develop a potential first-in-class & best-in-class T cell engager in autoimmune diseases with gamgertamig Management to host…
Subject to his election by shareholders, the Board intends to appoint Mr. Santini as Chair, succeeding Jérôme Contamine
De Raad van Bestuur is voornemens de heer Santini te benoemen tot Voorzitter, als opvolger van Jérôme Contamine, onder voorbehoud van zijn benoeming door aandeelhouders De heer Santini zal uitgebreide ervaring op het gebied van corporate governance, bedrijfsontwikkeling en leiderschap in de sector toevoegen aan de Raad van Bestuur Mechelen, België; 26 maart, 2026, 21:02 CET - Galapagos NV (Euronext and NASDAQ:…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for GLPG.
Senate Trading
No Senate trades found for GLPG.
U.S. House Trading
No House trades found for GLPG.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.